Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
NRG Oncology
NRG Oncology
University Health Network, Toronto
University of Michigan Rogel Cancer Center
NRG Oncology
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
Mayo Clinic
National Cancer Institute (NCI)
Children's Oncology Group
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group